Trulieve Cannabis Corp.

TRLV

NYSEHealthcareDrug Manufacturers - Specialty & Generic

Open in GoAI

Latest quote

$11.07

+$0.85 · +8.29%

Aug 21, 3:55 PM ET

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

47/100

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

Undervalued

Momentum

Neutral

Sentiment

Mixed

Risk resilience

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Headquarters: US
CEO: Kimberly A. Rivers
Listed since: Sep 25, 2018
Employees: 5,000

Market position

Volume: 1.55M; 1.53× average
Average volume: 1.01M; Average daily volume
Market cap: 1.89B USD
Beta: 1.72; Market reference 1

Financials

Financial snapshot

Latest / TTM

Financial health

Altman Z-score: 0.37
Piotroski F-score: 5 of 9

Earnings

Latest fiscal-year EPS: -0.61; FY2025
Latest fiscal-year revenue: 1.18B USD; FY2025
Next fiscal-year EPS consensus: -1.82; FY2026 · 4 analysts
Next fiscal-year revenue consensus: 1.01B USD; FY2026 · 6 analysts

Annual EPS trend

Reported history and fiscal-year consensus

ReportedConsensus forecast

Annual revenue trend

Reported history and fiscal-year consensus

ReportedConsensus forecast

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Recent analyst actions

1 institution

Cantor FitzgeraldmaintainOverweightAug 7, 2026

TRLV news

prnewswire.comAug 18, 2026

Trulieve to Ring The Closing Bell at the New York Stock Exchange as First U.S. Cannabis Company Listed on the NYSE

TALLAHASSEE, Fla., Aug. 18, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., announced it will ring The Closing…

Read source

marijuanastocks.comAug 12, 2026

3 Marijuana Stocks For Investors To Consider

What will help marijuana stock investors trade more, even in the midst of laws changing in the USA? It is no secret that nothing has moved pot stocks more than news of global reform or regulatory matters. For the US,…

Read source

prnewswire.comAug 11, 2026

Trulieve Completes Redomicile from British Columbia to Delaware

TALLAHASSEE, Fla., Aug. 11, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced the completion of…

Read source

seekingalpha.comAug 9, 2026

Trulieve Cannabis: First NYSE-Listed Cannabis Stock Is A Buy

Trulieve Cannabis (TRLV) is the first U.S. cannabis operator to uplist to the NYSE, unlocking broader investor access and liquidity. Recent catalysts include a $50 million share repurchase program and a profitable Q1…

Read source

marketbeat.comAug 9, 2026

Trulieve Cannabis Q2 Earnings Call Highlights

Trulieve Cannabis NYSE: TRLV reported second-quarter revenue of $271 million, while outlining plans to expand in Georgia and Texas following changes in medical cannabis regulations and the company's June listing on the…

Read source